Anil Sawant, MSc, PhD Merck Sharpe & Dohme, USA

Dr. Anil Sawant has more than 30 years of experience in the pharmaceutical industry in Quality & Compliance, Pharmaceutical Microbiology, Business Ethics, Auditing, and R&D functions.  He has worked on various dosage forms, and various product types, drugs, biologics, vaccines, medical devices, and consumer products.  He was of the teams that launched the first antibody-drug conjugate product and first photoactive drug in the US.   Currently, Anil is Sr. Vice President, Global Quality Transformation, Merck Sharpe & Dohme. He is currently focused on digital transformation of GMP systems supporting supply chains to increase global patient access.  Prior to joining MSD, Anil served in senior executive roles at Johnson & Johnson and at Pfizer. Anil has been a PDA Member and volunteer since 1992.  and is currently the Chair-Elect, PDA Board of Directors.   He is co-authored numerous PDA Technical Reports and position papers and lead the Data Integrity and COVID-19 Task Force. He has also published numerous scientific papers in infectious diseases, antimicrobials, and yeast physiology. Anil holds a B.Sc. Honors and a M.Sc. Honors in Microbiology & Biochemistry from Panjab University, India, and a PhD in Microbial and Biochemical Sciences from Georgia State University, Atlanta. He is recipient of the GSU Distinguished Alumni Achievement Award. Anil serves on the Board of the non-profit Mind Your Brain Foundation and has served on the Board of Directors of GSU Alumni Association.